CENTAGEN
Live / Registered — Registered (as of 14 Oct 2025)
What this means for you
Registered since 14 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97980668
- Registration number
- 7986312
- Mark type
- Stylized text
- Filed
- 17 Jun 2022
- Published for opposition
- 19 Dec 2023
- Registered
- 14 Oct 2025
- Attorney of record
- Aileen Law
Goods and services
- Class 042 — Scientific and technological services: Biochemical research; Biochemical research and development; Biotechnology research; Pharmaceutical research and development; Research and development in the field of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cardiovascular, immune system and inflammatory related diseases and disorders; Scientific research; Stem cell research services; Research and development of pharmaceuticals for the treatment of age-related diseases
Owner
- Centagen, Inc., Boulder, CO, US
- Centagen, Inc., Boulder, CO, US
- Centagen, Inc., Boulder, CO, US
Prosecution history
- 14 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 19 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Feb 2025 — USE AMENDMENT FILED
- 16 Sept 2025 — DIVISIONAL PROCESSING COMPLETE
- 13 Feb 2025 — DIVISIONAL REQUEST RECEIVED
- 03 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Feb 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 30 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 12 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2024 — SOU EXTENSION 1 GRANTED
- 12 Aug 2024 — SOU EXTENSION 1 FILED